Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-24 @ 7:35 PM
NCT ID:
NCT05643703
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥ 18 years, premenopausal female;
2. The scar is the transverse incision of the lower segment of the uterus (one or more times);
3. The following abnormal uterine bleeding occurred after cesarean section: prolonged menstruation/endless menstruation ≥ 14 days, menstrual bleeding;
4. Transvaginal three-dimensional ultrasound/pelvic MRI plain scan showed that the thickness of residual muscular layer at the top of diverticulum was less than 3 mm;
5. The effect of drug treatment is poor, and it is difficult to adhere to long-term drug treatment or surgical treatment;
6. HGB \> 100g/L before operation;
7. Hysteroscopy excluded endometrial lesions;
8. The patient or family members can understand the study protocol and voluntarily participate in the study, and provide written informed consent.
Exclusion Criteria:
1. The data of cesarean section is not complete, and the previous cesarean section method cannot be determined;
2. Abnormal uterine bleeding caused by endocrine disorders (thyroid dysfunction, luteal insufficiency), endometrial lesions, uterine fibroids, gynecological tumors, blood system diseases, pelvic infections, intrauterine devices, etc;
3. Infertility patients caused by female oviduct infertility, intrauterine adhesion infertility, uterine malformation, polycystic ovary syndrome, male infertility, etc;
4. Patients with other serious gynecological diseases and/or serious physical or psychological diseases;
5. Pregnancy (women of childbearing age were positive in pregnancy test at baseline or did not receive pregnancy test), and women in lactation;
6. Patients who are unable to complete the follow-up;
7. The patient or family members could not understand the conditions and objectives of the study and did not agree to participate in the study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT05643703
Study Brief:
Protocol Section:
NCT05643703